A-ALPHA BIO INC — National Science Foundation SBIR Phase I: BT
A-ALPHA BIO INC — SBIR Phase I award from National Science Foundation.
- Amount
- $256,000
- Agency
- National Science Foundation
- Program / Phase
- SBIR · Phase I
- Topic
- BT
- NAICS
- —
- Place of performance
- WA
- Period
- 2020-09-01 → 2021-08-31
Description
The broader impact of this Small Business Innovation Research (SBIR) Phase I project is to improve and accelerate the development of antibody therapies to fight the COVID-19 pandemic. Antibody therapies are in development to target SARS-CoV-2, the virus r